Renal Cell Carcinoma

>

Latest News

Roundtable Roundup: Frontline Renal Cell Carcinoma Therapy
Roundtable Roundup: Frontline Renal Cell Carcinoma Therapy

March 17th 2023

In separate live, virtual events, Ulka N. Vaishampayan, MBBS, and David A. Braun, MD, PhD, discussed options for a patient with favorable-risk clear cell renal cell carcinoma.

Campbell Discusses Choices for Patients With Favorable- and Intermediate-Risk RCC
Campbell Discusses Choices for Patients With Favorable- and Intermediate-Risk RCC

March 8th 2023

Cabozantinib Plus Atezolizumab Does Not Prolong PFS in Advanced RCC
Cabozantinib Plus Atezolizumab Does Not Prolong PFS in Advanced RCC

March 3rd 2023

Roundtable Discussion: Voss Looks at Integrating New Approaches in Clear Cell RCC Treatment
Roundtable Discussion: Voss Looks at Integrating New Approaches in Clear Cell RCC Treatment

February 27th 2023

Moshe Ornstein, MD, an expert on renal cell carcinoma
Recent Advances in the Management of Advanced Renal Cell Carcinoma (RCC)

February 24th 2023

Video Series
Video Interviews
Podcasts

More News